Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.

Portal Biotechnologies and Multiply Labs announced a collaboration with the goal of leveraging automation to accelerate product timelines and reduce costs, helping innovative cell therapies reach more ...

Cardiovascular Reparative Medicine and Tissue Engineering (CRMTE) aims to develop future technologies and therapeutic strategies that will serve as treatment for cardiovascular disease. CRMTE includes ...

Regenerative medicine combines tissue engineering and cell therapies to repair or replace damaged human tissues and organs. Key applications include treating osteoarthritis with mesenchymal stem cells ...

Cells can now be genetically programmed to record their histories within their genomes, a development that could revolutionize the study of developmental and disease processes, according to a ...

When immune cells go awry and spark inflammation, a different type of immune cell stands ready to counteract that effect and return the immune system to a state of balance. Therapies based on such ...

Bioengineers have developed a new construction kit for building custom sense-and-respond circuits in human cells. The research could revolutionize therapies for complex conditions like autoimmune ...

Advanced therapeutics, such as cell engineering, gene therapy, and immune engineering, comprise the next generation of life-enhancing and curative interventions. As new therapies gain approval, the ...

Widely used as a genome editing tool, the CRISPR-Cas9 system allows researchers to precisely induce frameshift mutations in specific genes or insert foreign nucleic acid sequences into a cell’s DNA.

These factors prompted research into better and more permanent treatments for T1D. The most obvious solution: restore the natural repertoire of β cell islets. Although most recipients experienced ...